NFKB1 and inflammatory bowel disease: In addition, inhibition of NF-κB leads to inhibition of iNOS in the intestinal mucosa with a decreased generation of ROS and reactive nitrogen species with subsequent amelioration of oxidative stress in inflammatory bowel diseases [40].